(Date:12/1/2008)...ire-FirstCall/ -- SpectraScience, Inc.,(OTC Bulle... company, today,announced that it has been awarde... for Tissue Diagnosis. , Jim Hitchin, SpectraSc...to,the Company,s optical biopsy technology becaus...urveillance, characterization, diagnosis and treat...
(Date:12/1/2008)... higher risk for SIDS and this may be why, researc...ews) -- Premature infants often have lower-than-no... six months of life and may be one reason these in...me (SIDS), Australian researchers suggest. , On...n blood pressure during sleep, from which the infa...
(Date:12/1/2008)...RNewswire-USNewswire/ -- As part of the Dec. 1 o...ealth Everette James today urged Pennsylvanians to...e also highlighted ongoing efforts to educate the ..., , "Our message is clear: regardless of yo...ing tested for HIV is the only sure way to know yo...
(Date:12/1/2008)...hers used a new imaging technique to take high qua...cular inflammation in mice, and the technology cou...s of the eye that may cause blindness. , The stu...immune Uveoretinitis Using Topical Endoscopic Fund... Correlation," was published in the Association fo...
Breaking Medicine News(10 mins):Health News:SpectraScience Awarded European Patent for Its Optical Biopsy System for Tissue Diagnosis 2Health News:Preemies' Low Blood Pressure Linked to SIDS 2Health News:Preemies' Low Blood Pressure Linked to SIDS 3Health News:PA Department of Health Recognizes 20th Anniversary of World AIDS Day; Urges HIV Testing 2Health News:New technique captures high-res images of full retina 2... study has dismissed any association between consu... study examined the association between total calc...t. Diet and calcium supplements formed the main so... 19,000 men between the age of 40 and 75 years wer...
...n is a sleeping pill. But lately it is has been li... drivers. Wisconsin officials identified Ambien in...cials say that there are signs that Ambien-related... Sanofi-Aventis said that the drug is safe when ta...
...ne with the International Women’s Day celebrations... the Chennai-based Apollo hospitals. Ms. J. Jayala...women health care center on Wednesday. // The hea...all health problems of the women folk including su...
... University of Toronto study by Professor David Je...holesterol-lowering foods as soy protein, almonds,... these may reduce cholesterol levels more effectiv... study is published in American Journal of Clinica...
Other Medicine News:Health News:Ambien Plus Alcohol Has A Bad Influence on the Drivers 2Health News:Try a consortia of cholesterol-lowering foods for best results 2(Date:11/25/2008)... 25 Poniard,Pharmaceuti...company focused on,innovative oncology therapies,...gic alternatives for its preclinical research prog...esources on the clinical development of picoplatin...initial commercialization of,picoplatin in the tr...
(Date:11/24/2008)..., Nov. 24 Takeda Pharmaceutical Co...eda Global Research & Development Center, Inc....y Committee of the U.S. Food and Drug Administrati...at for the treatment of hyperuricemia in patients...proval, with one panel member abstaining. The vote...
(Date:11/24/2008)...leadership and long-term commitment to hepatitis r...wswire-FirstCall/ -- Schering-Plough Corporation (...boceprevir, its lead investigational oral hepatiti...lopment. The company believes boceprevir has the ... protease inhibitor for treating chronic hepatitis...
(Date:11/24/2008)...wswire-FirstCall/ -- GeneThera, Inc.,(Pink Sheets...its Real Time,PCR test for Johne,s disease throug...Thera is set to begin offering its Johne,s disease...ording to GeneThera Chairman, Dr. Tony Milici MD,...R test for Johne,s disease,called HerdGuard(TM) ...
Breaking Medicine Technology:Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 2Poniard Pharmaceuticals Announces Management Changes and Focus on Development and Commercialization of Picoplatin 3Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 2Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 2Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 3Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 4Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 5Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 6Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 7Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 8Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C 9GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 2GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 3GeneThera Announces it is Set to Begin Commercial Testing for Johne's Disease as Soon as January, 2009. 4Lifetime Television Launches Third Annual Dont Skip a Beat Multi Platform Heart Health Awareness Initiative 10786 1Lifetime Television Launches Third Annual Dont Skip a Beat Multi Platform Heart Health Awareness Initiative 10786 2Lifetime Television Launches Third Annual Dont Skip a Beat Multi Platform Heart Health Awareness Initiative 10786 3Election 2008 3A Sleep deprivation a tough opponent for presidential candidates 10781 1Election 2008 3A Sleep deprivation a tough opponent for presidential candidates 10781 2MDS Inc Files Restated 2007 Quarterly Reports Under US GAAP 10779 1On Heels of SCHIP Veto President Advocates Eliminating Federal Funding for Training Childrens Doctors 10775 1On Heels of SCHIP Veto President Advocates Eliminating Federal Funding for Training Childrens Doctors 10775 2...WIRE)--Apr 18, 2007 - Nymox,Pharmaceutical Corpora...a new 42 month follow-up study of NX-1207 for beni...d symptomatic,progress of U.S. patients involved i... 2003. Individuals in the study were assessed,for ...urability of,efficacy. Patients in the study were ...
...ion for Cancer Research Annual,Meeting, SAN DIEGO,...,Pharmaceuticals, Inc. , a biopharmaceutical resea...zing proprietary product,candidates for the treatm...nced positive results from preclinical studies usi... (CoFactor(R)) at the,American Association for Can...
Other Medicine Technology:Nymox Reports Completion of New 42 Month Follow-up Study of NX-1207,for BPH 2Adventrx Announces Positive Data From Multidrug Therapy With,CoFactor 2Adventrx Announces Positive Data From Multidrug Therapy With,CoFactor 3Adventrx Announces Positive Data From Multidrug Therapy With,CoFactor 4... of cerclage wiring, the Cable-Ready Cable Grip1 S...e minimizing invasion of the wound site. The syste... technique. , ,The Cable-Ready Cable Grip system ...y involving: Olecranon Fractures, Femur Fractures,...
The Assistant Free Self-Retaining Hip Surgery Retractor System is used for hip arthroplasty and hip fracture surgery.
The Taperloc femoral component is a collarless flat wedge-shaped implant that provides excellent durability and stability in a design that is relatively simple and predictable to implant. The incorpo
Build your Basic Small Joint Set from the suggested instruments or select other insruments for the set.
Medicine Products: